Thinkmd - Medsinc | Engineering For Change

Product Description

MEDSINC is a simple-to-use, self-training, mobile, integrated clinical assessment software platform that enables minimally skilled users to effectively assess how sick a child is and provide immediate triage and treatment recommendations. Targeting children two months to five years, MEDSINC guides users through a clinical severity assessment for four critical clinical conditions: respiratory distress, dehydration, infection risk (sepsis), and malnutrition, as well as eight common diagnoses.
Demo video.

Target SDGs

SDG 3: Good Health and Well-Being

Target Users (Target Impact Group)

Community

Distributors / Implementing Organizations

THINKMD will distribute its product through channel partners, private and public.

Manufacturing/Building Method

Software development.

Intellectural Property Type

Select Type

User Provision Model

Clients request a demo through the website.

Distributions to Date Status

Thousands of users between clinics and partner NGOs.

Design Specifications

1) Gather patient demographics; 2) Collect symptoms and illness history; 3) Capture key vital signs and physical findings.

Product Schematics

Technical Support

Available.

Replacement Components

N/A

Lifecycle

N/A

Manufacturer Specified Performance Parameters

50 million preventable childhood deaths by 2030.

Vetted Performance Status

MEDSINC platform already delivers 80 to > 95% correlations . For every 1000 MEDSINC users:

300 child lives saved
$19.4 M in productivity gains from a decrease in morbidity and mortality
4.5x increase in compliance with WHO protocols

Safety

N/A

Complementary Technical Systems

N/A

Academic Research and References

Rodney Nascimento Guimarães, Zilma Reis, May 2017, A multiband reflectance photometric device for reveal gestational age at birth

Compliance with regulations

Unknown.

Evaluation methods

MEDSINC has been validated with world-class partners in 5 countries on 4 continents. Accuracy and usability has been confirmed through rigorous user testing and side-by-side clinical trials.

Other Information

None.